A comprehensive view of Novavax Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
NOVAVAX INC - (8-K) - Disclosing Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Published:
May 13, 2024
by SEC Edgar Filings
|
Novavax Inc. - Material Agreement - Form 8-K
Published:
May 13, 2024
by U.S. Markets (Alternative Disclosure) via PUBT
|
Novavax to Participate in BofA Securities 2024 Health Care Conference
Published:
May 13, 2024
by Novavax Inc.
|
Sanofi Enters into Licensing Agreement with Novavax
Published:
May 13, 2024
by Marketline - Deals
|
Novavax signs deal with Sanofi to license vaccines
Published:
May 10, 2024
by CE Noticias Financieras (Latin America)
|
Ask us about our Consumer Wellness market view